ConductScience.org, home

Paper856558

The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.

Deano DA and 5 others. Chest, 1977. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. Papers, record 856558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/856558

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
PubMed
Journal
Chest
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
4.02
iCite
Revised in PubMed
2019-05-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deano DAD A
2Wu DD
3Mautner RKR K
4Sherman RHR H
5Ehsani AIA I
6Rosen KMK M

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arrhythmias, CardiacMajor topic
DisopyramideMajor topic
PyridinesMajor topic
Administration, Oral
Adult
Aged
Atrial Fibrillation
Atrial Flutter
Drug Evaluation
Female
Humans
Injections, Intravenous
Male
Middle Aged
Tachycardia
Tachycardia, Paroxysmal
Wolff-Parkinson-White Syndrome

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
7426181Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.Br Heart J1980https://conductscience.org/library/papers/7426181PubMed
7215416Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7215416PubMed
6876690Effect of intravenous flecainide on atrial vulnerability in man.Klin Wochenschr1983https://conductscience.org/library/papers/6876690PubMed
6849716Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways.Br Heart J1983https://conductscience.org/library/papers/6849716PubMed
6840167Plasma concentration of disopyramide given as capsules and controlled release tablets.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6840167PubMed
6800757New antiarrhythmic drugs: their place in therapy.Drugs1981https://conductscience.org/library/papers/6800757PubMed
6762414Clinical pharmacokinetics of disopyramide.J Pharmacokinet Biopharm1982https://conductscience.org/library/papers/6762414PubMed
6161824Efficacy of intravenous disopyramide in acute cardiac arrhythmias.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/6161824PubMed
4074615The influence of age and smoking on the elimination of disopyramide.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4074615PubMed
4006774Effect of intravenous flecainide on atrial vulnerability in man.Drugs1985https://conductscience.org/library/papers/4006774PubMed
3987784Atenolol inhibits the elimination of disopyramide.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3987784PubMed
3987780Cardioversion with flecainide in patients with atrial fibrillation of recent onset.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3987780PubMed
3780831Kinetics of disopyramide in decreased hepatic function.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3780831PubMed
3304965Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.Drugs1987https://conductscience.org/library/papers/3304965PubMed
316334Haemodynamic effects of disopyramide in patients after open-heart surgery.Br Heart J1979https://conductscience.org/library/papers/316334PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/856558

GET https://conductscience.org/api/papers/v1/856558/authors